Migraine and adverse pregnancy outcomes: the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be - 23/08/22
Plan
The authors report no conflict of interest. |
|
E.C.M. is supported by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (K23NS107645, R01NS122815) and the Gerstner Family Foundation (Gerstner Scholars Program). N.A.B. is supported by the NIH National Heart, Lung, and Blood Institute (K23-HL136853, R01-HL153382) and the NIH Loan Repayment Program (1L30HL129418-03). The Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be study was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): U10 HD063036, RTI International; U10 HD063072, Case Western Reserve University; U10 HD063047, Columbia University; U10 HD063037, Indiana University; U10 HD063041, University of Pittsburgh; U10 HD063020, Northwestern University; U10 HD063046, University of California Irvine; U10 HD063048, University of Pennsylvania; and U10 HD063053, The University of Utah. |
|
Preliminary findings of this study were presented at the 68th annual meeting of the Society for Reproductive Investigation, Boston, MA, July 6–9, 2021, and the 2022 annual meeting of the American Academy of Neurology, Seattle, WA, April 2–7, 2022. |
Vol 227 - N° 3
P. 535-536 - septembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?